Novartis made one of the biggest investments in Cannes among pharma companies, sending approximately 20 people from the organization to the creativity festival. They came with multiple goals, ...

Lab equipment maker Waters Corp will merge with larger rival Becton, Dickinson and Company's Biosciences & Diagnostic Solutions business in a $17.5 billion Reverse Morris Trust deal, the companies ...

Lawmakers bet millions on pharma stocks as Trump targets industry Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Bioventus Inc. (NASDAQ: BVS) Q1 2025 Results Conference Call May 6, 2025 8:30 AM ET Company Participants Dave Crawford - Investor Relations Rob Claypoole - President & Chief Executive Officer Mark ...

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

The president gave no details on the pharmaceutical tariffs. Trump unleashed a sweeping slate of tariffs on friends and foes alike last week, sending stocks plunging and roiling the global economy.

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Bioventus (BVS – Research Report). The company’s shares closed last Friday at $9.20.

Common Side Effects, Adult Swim's latest animated series, is a conspiracy thriller that takes a much-deserved sledgehammer to Big Pharma.

There's more than meets the eye on the famous Coke logo. Here are all the details, plus the evolution of this distinctive design.

The evolution of Pharma 4.0 integrates advanced technologies, transforming drug development and manufacturing with improved efficiency and product quality.

Bravura Solutions Ltd. Annual cash flow by MarketWatch. View BVS net cash flow, operating cash flow, operating expenses and cash dividends.

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...